Creditas considers issuance of new USD senior unsecured bonds and partial buy-back offer in outstanding USD senior unsecured bonds 2023/2026 November 24, 2024
Lytix Biopharma – Licensing partner Verrica Pharmaceuticals announces pricing of underwritten public offering, raising approximately USD 42 million upon completion November 21, 2024
NORDEN reports net profit of USD 25 million in Q3 2024 and continues to return cash to shareholders October 31, 2024
PopVax Announces 1.15 Million USD in Funding from the Bill and Melinda Gates Foundation for Thermostable mRNA Delivery Formulation Development October 30, 2024